When consumers search for Maqui Berry, eye health is usually part of the conversation — search data shows Maqui closely associated with ingredients like astaxanthin, lutein, and bilberry, all recognized for ocular antioxidant support. That connection isn't accidental: Maqui's high concentration of delphinidins, a rare and potent class of antioxidants, is what links the fruit to this category in the first place.
MNL Group's two Maqui-derived ingredients, MaquiBright® and Maqui XT® Powder, both draw from that same antioxidant-rich profile. MaquiBright® is the one with the clinical trial behind it, patented and standardized specifically for eye-health outcomes. Maqui XT® Powder shares the same delphinidin-rich origin, but rather than a single clinical claim, it's built to carry Maqui's antioxidant strength into functional food and beverage formats.
Every MNL Group ingredient starts in the same place: wild-harvested Maqui Berry (Aristotelia chilensis) from the forests of Chilean Patagonia. From that shared starting point, MNL Group processes the berry differently depending on the application it's built for.
MaquiBright® is MNL Group's patented, clinically studied extract, standardized to ≥25% delphinidins and ≥35% total anthocyanins. It's the ingredient behind a randomized, double-blind, placebo-controlled trial showing a 25% increase in tear fluid production after 4 weeks, and roughly 75% reduction in dry-eye symptom severity after 60 days. That level of documentation is what makes MaquiBright® the ingredient of choice when a brand needs a specific, substantiated eye-health claim — most commonly formulated into capsules, tablets, and sachets.
Maqui XT® Powder carries Maqui's antioxidant profile in concentrated form, standardized to ≥25% total anthocyanins and ≥20% delphinidins through a solvent-free extraction process. That concentrated antioxidant base, combined with high water solubility and a clean label, is what makes Maqui XT® Powder the practical choice for functional beverages, antioxidant shots, bars, and other formats where a strong Maqui presence needs to blend into the product itself, not sit inside a capsule shell.
MaquiBright® at a glance
Maqui XT® Powder at a glance
Formulating a capsule, tablet, or sachet — especially for eye health? MaquiBright® is the natural fit. It's the format it was designed for, and the one behind the eye-health clinical trial data: a 25% increase in tear fluid production and roughly 75% reduction in dry-eye symptom severity in controlled studies.
Formulating a beverage, shot, or functional food? Maqui XT® Powder is the practical choice. Its solvent-free, water-soluble profile is built specifically for liquid and food formats — the same reason it's the ingredient MNL Group sees used most often across functional beverage and food applications today.
Some formulators use both across a product line — MaquiBright® in a targeted eye-health capsule, Maqui XT® Powder in a broader antioxidant ingredient — since both draw from the same traceable Patagonian source, applied to the format each was built for.
Looking to explore Maqui Berry ingredients beyond these two? MNL Group's guide to Maqui Berry powder and extracts in functional foods breaks down how Maqui XT® Powder compares to whole-fruit Freeze-Dried Maqui Berry Powder.
Request technical documentation or a sample of MaquiBright® or Maqui XT® Powder.
What is the difference between MaquiBright® and Maqui XT® Powder?
MaquiBright® is a patented, clinically studied extract standardized to ≥25% delphinidins, developed specifically for eye-health applications and backed by a randomized controlled trial. Maqui XT® Powder is a solvent-free, water-soluble concentrate standardized to ≥20% delphinidins, built to carry Maqui's antioxidant strength into beverages, functional foods, and general-purpose supplements. Both originate from the same wild-harvested Patagonian Maqui Berry.
Do MaquiBright® and Maqui XT® Powder have the same health benefits?
Both come from the same delphinidin-rich Maqui Berry and share the same antioxidant compound family. Where they differ is how that shared profile is put to use: MaquiBright® is standardized and clinically studied specifically for eye-health outcomes, while Maqui XT® Powder is built to carry Maqui's antioxidant strength into a wider range of formats, like beverages and functional foods, without a dedicated clinical claim of its own. Each ingredient is formulated to perform best in the application it was designed for.
Why is Maqui XT® Powder better suited for beverages?
Maqui XT® Powder is produced through a solvent-free extraction process and is highly water-soluble, which allows it to blend cleanly into liquid formats like functional beverages, antioxidant shots, and drink mixes — something that's harder to achieve with capsule-oriented extracts.
Can Maqui XT® Powder be used in the same applications as MaquiBright®?
Maqui XT® Powder can be used in supplements, but it doesn't carry MaquiBright®'s clinical substantiation for eye health. Brands looking for a specific, trial-backed claim typically choose MaquiBright®; brands looking for a versatile, antioxidant-rich ingredient for beverages, foods, or general-purpose supplements typically choose Maqui XT® Powder.
Clinical study cited
Yamashita S, Suzuki N, Yamamoto K, Iio S, Yamada T. "Effects of MaquiBright® on improving eye dryness and fatigue in humans: A randomized, double-blind, placebo-controlled trial." Journal of Traditional and Complementary Medicine, 2019;9(2):172–178.
View study (DOI) →⚠ These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease. MaquiBright® and Maqui XT® are nutraceutical ingredients supplied to manufacturers, not finished consumer products.